Cost-effectiveness of a lifestyle intervention in preventing Type 2 diabetes. (Q48567617)

12 February 2018

title

Cost-effectiveness of a lifestyle intervention in preventing Type 2 diabetes. (English)

1 reference

12 February 2018

1 reference

5

1 reference

12 February 2018

author name string

Lisa Irvine

1

1 reference

12 February 2018

Garry R Barton

2

1 reference

12 February 2018

Amy V Gasper

3

1 reference

12 February 2018

Nikki Murray

4

1 reference

12 February 2018

Tracey Scarpello

6

1 reference

12 February 2018

Mike Sampson

7

1 reference

12 February 2018

publication date

1 October 2011

1 reference

12 February 2018

International Journal of Technology Assessment in Health Care

published in

1 reference

12 February 2018

volume

27

1 reference

12 February 2018

page(s)

275-282

1 reference

12 February 2018

issue

4

1 reference

12 February 2018

Representing uncertainty: the role of cost-effectiveness acceptability curves.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

The changing prevalence of diagnosed diabetes and its associated vascular complications in a large region of the UK.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

EuroQol: the current state of play

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

The Diabetes Prevention Program (DPP): description of lifestyle intervention

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

Dispensing patterns and financial costs of glucose-lowering therapies in the UK from 2000 to 2008.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

Cost-effectiveness of a day hospital falls prevention programme for screened community-dwelling older people at high risk of falls

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

The use of unequal randomisation ratios in clinical trials: a review.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

The time trade-off method: results from a general population study.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

Cost effectiveness of preventive interventions in type 2 diabetes mellitus: a systematic literature review.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

Multiple imputation in health-care databases: an overview and some applications

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

Collecting unit cost data in multicentre studies. Creating comparable methods

1 reference

https://api.crossref.org/works/10.1017%2FS0266462311000365

7 January 2021

10.1017/S0266462311000365

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

22004767

1 reference

12 February 2018